226330 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Syntekabio, Inc. is a bioinformatics company. It manages and analyzes genome analysis and massive bio data and genome. The company was founded by Jongsun Jung in 2009 and is headquartered in Daejeon, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
226330 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company